Rosiglitazone treatment of HIV-associated lipodystrophy syndrome:: impact on the bioavailability of antiretroviral compounds

被引：0
|
作者：
Oette, M
Göbels, K
Kurowski, M
Kroidl, A
Feldt, T
Wettstein, M
Häussinger, D
机构：
[1] Univ Dusseldorf, Gastroenterol Clin, D-4000 Dusseldorf, Germany
[2] Auguste Viktoria Krankenhaus, Berlin, Germany
来源：
ANTIVIRAL THERAPY | 2003年 / 8卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
115
引用
收藏
页码：L77 / L77
页数：1
相关论文
共 50 条
  • [1] Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome
    Feldt T.
    Oette M.
    Kroidl A.
    Goebels K.
    Fritzen R.
    Kambergs J.
    Kappert G.
    Vogt C.
    Wettstein M.
    Häussinger D.
    [J]. Infection, 2006, 34 (2) : 55 - 61
  • [2] Evaluation of safety and efficacy of rosiglitazone in the treatment of HIV-associated lipodystrophy syndrome
    Feldt, T.
    Oette, M.
    Kroidl, A.
    Goebels, K.
    Fritzen, R.
    Kambergs, J.
    Kappert, G.
    Vogt, C.
    Wettstein, M.
    Haeussinger, D.
    [J]. INFECTION, 2006, 34 (02) : 55 - 61
  • [3] HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy
    Giovanni Guaraldi
    Chiara Stentarelli
    Stefano Zona
    Antonella Santoro
    [J]. Drugs, 2013, 73 : 1431 - 1450
  • [4] HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy
    Guaraldi, Giovanni
    Stentarelli, Chiara
    Zona, Stefano
    Santoro, Antonella
    [J]. DRUGS, 2013, 73 (13) : 1431 - 1450
  • [5] Impact of rosiglitazone treatment on the bioavailability of antiretroviral compounds in HIV-positive patients
    Oette, M
    Kurowski, M
    Feldt, T
    Kroidl, A
    Sagir, A
    Vogt, C
    Wettstein, M
    Häussinger, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (02) : 416 - 419
  • [6] HIV-associated lipodystrophy syndrome
    Qaqish, RB
    Fisher, E
    Rublein, J
    Wohl, DA
    [J]. PHARMACOTHERAPY, 2000, 20 (01): : 13 - 22
  • [7] HIV-associated lipodystrophy syndrome
    Milinkovic, Ana
    [J]. COLLEGIUM ANTROPOLOGICUM, 2006, 30 : 59 - 62
  • [8] The HIV-associated lipodystrophy syndrome
    Mauss, S
    Schmutz, G
    [J]. MEDIZINISCHE KLINIK, 2001, 96 (07) : 391 - 401
  • [9] HIV-associated lipodystrophy syndrome
    Mauss, S
    [J]. AIDS, 2000, 14 : S197 - S207
  • [10] Risk factors for the HIV-associated lipodystrophy syndrome in patients with uniform duration of antiretroviral treatment (LipART)
    Mauss, S
    Corzillius, M
    Wolf, E
    Schwenk, A
    Jaeger, H
    Knechten, H
    Goelz, J
    Goetzenich, A
    [J]. AIDS, 2000, 14 : S54 - S54
12345